Skip to main content
. 2022 Dec 15;10(12):3258. doi: 10.3390/biomedicines10123258

Figure 3.

Figure 3

Pharmacological strategies for management of main causes and symptoms of diabetic cardiac autonomic neuropathy (DCAN). ACE, angiotensin-converting enzyme; GLP-1R, receptor for glucagon-like peptide-1; SGLT-2, sodium/glucose cotransporter 2; AR, aldose reductase. Source: Own authorship.